JPM: Viatris CEO trumpets ‘disciplined’ deal-making for postmerger roadmap
Now that Mylan and Pfizer’s Upjohn established medicine business have officially combined to become Viatris, CEO Michael Goettler has laid out a growth roadmap for...
Viatris
Viatris’ growth story hinges on M&A as China, Japan hang in the balance: analyst
After months of delay thanks to a U.S. antitrust roadblock, Pfizer and Mylan finally wrapped up their generics merger on Monday. Enter Viatris, which hopes...